Headline
The latest stories from AHA Today.
An updated set of Current Procedural Terminology codes includes two for reporting medical services necessitated during the COVID-19 pandemic public health response.
The AHA again expressed concern to the Department of Health and Human Services about recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to hospitals.
The Louisiana Hospital Association Research and Education Foundation has established a fund to help hospital employees who experienced significant property loss or personal hardship as a result of Hurricane Laura.
The National Institutes of Health announced as part of its Rapid Acceleration of Diagnostics initiative $129.3 million in contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24…
The Food and Drug Administration approved a new drug for facilitating tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
The Federal Reserve Sept. 4 said that its Main Street Lending Program is now fully operational and accepting submissions of eligible loans to nonprofit organizations.
The Centers for Medicare & Medicaid Services issued new surveyor guidance for COVID-19 laboratory test result reporting for Clinical Laboratory Improvement Amendments-certified laboratories.
Senate Republican leaders released a roughly $500 billion COVID-19 relief package that would provide additional assistance for priorities, including small businesses, enhanced unemployment insurance, child care, COVID-19 testing and schools.
The Centers for Medicare & Medicaid Services released the preliminary calendar 2019 unaudited occupational mix survey data, which will be used in area wage index calculations beginning in fiscal year 2022.
The AHA urged the National Academies of Sciences, Engineering and Medicine to adopt a unified set of guidelines to account for the variables associated with all issues of the eventual allocation of COVID-19 vaccine allocation.